The stock of Allakos Inc (ALLK) has gone down by -2.98% for the week, with a -17.82% drop in the past month and a -43.49% drop in the past quarter. The volatility ratio for the week is 7.83%, and the volatility levels for the past 30 days are 10.54% for ALLK. The simple moving average for the past 20 days is -11.54% for ALLK’s stock, with a -56.58% simple moving average for the past 200 days.
Is It Worth Investing in Allakos Inc (NASDAQ: ALLK) Right Now?
Company’s 36-month beta value is 1.17.Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 2 as “overweight,” 1 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for ALLK is 76.12M, and currently, short sellers hold a 2.55% ratio of that floaft. The average trading volume of ALLK on September 19, 2024 was 546.62K shares.
ALLK) stock’s latest price update
The stock price of Allakos Inc (NASDAQ: ALLK) has surged by 7.80 when compared to previous closing price of 0.54, but the company has seen a -2.98% decline in its stock price over the last five trading sessions. globenewswire.com reported 2024-08-07 that SAN CARLOS, Calif., Aug. 07, 2024 (GLOBE NEWSWIRE) — Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company developing antibodies for the treatment of allergic, inflammatory and proliferative diseases, today provided a business update and reported financial results for the second quarter ended June 30, 2024.
Analysts’ Opinion of ALLK
Many brokerage firms have already submitted their reports for ALLK stocks, with Jefferies repeating the rating for ALLK by listing it as a “Hold.” The predicted price for ALLK in the upcoming period, according to Jefferies is $1.50 based on the research report published on January 17, 2024 of the current year 2024.
ALLK Trading at -21.05% from the 50-Day Moving Average
After a stumble in the market that brought ALLK to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -82.90% of loss for the given period.
Volatility was left at 10.54%, however, over the last 30 days, the volatility rate increased by 7.83%, as shares sank -21.54% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -29.35% lower at present.
During the last 5 trading sessions, ALLK fell by -2.27%, which changed the moving average for the period of 200-days by -74.28% in comparison to the 20-day moving average, which settled at $0.6500. In addition, Allakos Inc saw -78.68% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ALLK starting from Alexander Robert, who proposed sale 37,311 shares at the price of $0.58 back on Sep 11 ’24. After this action, Alexander Robert now owns shares of Allakos Inc, valued at $21,805 using the latest closing price.
Lee Chin Hyok, the Officer of Allakos Inc, proposed sale 45,320 shares at $0.65 during a trade that took place back on Sep 09 ’24, which means that Lee Chin Hyok is holding shares at $29,336 based on the most recent closing price.
Stock Fundamentals for ALLK
Current profitability levels for the company are sitting at:
- -17.44 for the present operating margin
- 0.53 for the gross margin
The net margin for Allakos Inc stands at -19.15. The total capital return value is set at -1.56. Equity return is now at value -121.54, with -86.62 for asset returns.
Based on Allakos Inc (ALLK), the company’s capital structure generated 0.32 points at debt to capital in total, while cash flow to debt ratio is standing at -2.6. The debt to equity ratio resting at 0.47. The interest coverage ratio of the stock is -70.99.
Currently, EBITDA for the company is -189.91 million with net debt to EBITDA at -0.07. When we switch over and look at the enterprise to sales, we see a ratio of 6.05. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.57.
Conclusion
In a nutshell, Allakos Inc (ALLK) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
